Animal Vaccines Industry Overview
The global animal vaccines market size was valued at USD 11.8 billion in 2021 and is expected to reach USD 26.12 billion by 2030, registering a CAGR of 9.3% over the forecast period. The increasing outbreaks of cattle disease and the ever-expanding livestock population are the prime factors for the wide acceptance of the ruminants especially cattle vaccines globally. Animals serve as a vital source of meat, protein, food, milk, and other commercial products such as wool and leather. Most used animal vaccines comprise rabies vaccines, equine influenza virus vaccines, and foot and mouth diseases vaccines, which prevent the transmission of infectious agents by mimicking the naturally acquired immunity.
Rising concerns over food security and increasing animal husbandry are boosting the demand for animal vaccines for the livestock population. Increasing demand for animal products has led to growth in livestock production globally. Furthermore, various factors such as variation in food preferences due to changing lifestyles and population growth are increasing the demand for livestock products. These factors are aiding in the growth of the market. Furthermore, the perpetual introduction of technologically advanced vaccines and the outbreak of livestock diseases have contributed to the shifting market dynamics.
Gather more insights about the market drivers, restrains and growth of the Global Animal Vaccines market
The market saw moderate growth in 2020. The COVID-19 pandemic has impacted all industries, including animal vaccines. During the initial time of the pandemic, OIE has confirmed that no animals can spread this virus. However, human-to-animal transmission has been reported in a few countries. IDEXX Laboratories and other companies have tested many dogs and cats for the virus, with test results being negative. In the initial months of the pandemic, there was speculation that it may spread through birds, which negatively impacted the livestock industry. In the U.S., several pig and poultry processing plants shut down after the major outbreak. The poultry sector of India has already lost around USD 1 billion due to fears and concerns about the novel coronavirus.
In December 2020, a bird flu outbreak was reported in 9 Indian states. Due to this, the price of poultry products has gone down, severely affecting the overall livestock industry. According to the Poultry Federation of India, chicken consumption has reduced to 50%, with a drop of 30% in the prices, as of December 2020. While most of the Asian countries have adopted vaccination policies, India has primarily resorted to the culling of birds. Punjab and Haryana state governments are close to legalizing vaccinations, which can positively impact the market growth.
The coronavirus spreads from animal to animal with contact or aerosol transmission, thus infecting other animals. Incidents such as COVID-19 infected farmed minks were reported in numerous nations such as the U.S. and Denmark during late 2020. Thereby, such incidents have triggered the need for the COVID-19 animal vaccine. As a result, the market players are getting involved to manufacture veterinary vaccines against COVID-19. For instance, Zoetis is in process of donating over 11,000 doses of its experimental COVID-19 vaccine to help protect the health and well-being of Zoo animals. On the other hand, in April 2021, Russia has registered the world’s first Covid-19 vaccine called Carnivac-Cov for animals. Thus, the growing cases of COVID-19 infections in domestic and wild animals will promote the acceptance of animal vaccines for safeguarding preventive animal health, thus soaring the industry growth.
In June 2021, the U.K. announced the establishment of a U.K. Animal Vaccine Manufacturing and Innovation Centre in Surrey, intending to accelerate the vaccine development for livestock and to control the spread of viral diseases including coronavirus. The U.K. government will contribute USD 24.79 million while the Bill & Melinda Gates Foundation will contribute USD 19.43 million to establish this center. Thereby, the research initiatives adopted by the market players, growing COVID-19 infection cases in animals, and government support will enable the significant expansion of the animal vaccines industry.
The increasing prevalence of zoonotic diseases can negatively impact human lives, which is likely to boost the demand for animal vaccines. Emerging and exotic animal diseases are a growing threat to human and animal health and jeopardize food security. The rise in the population of both humans and animals along with environmental degradation and globalized trade and travel improves opportunities for the transmission of pathogens within and between species. The resulting ailments pose massive challenges currently and in the future. In most of the world, improved demand for animal protein has resulted in increased commercial food animal production. Emerging zoonotic diseases of both companion and livestock animals are a major threat to public health. The world will inevitably continue to experience emerging disease outbreaks in the coming decades. Therefore, animal vaccines can play a crucial role in controlling emerging diseases.
Animal Vaccines Market Segmentation
Based on the Product Insights, the market is segmented into Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, and Recombinant Vaccines.
- The attenuated live vaccines segment dominated the market for animal vaccines and accounted for a revenue share of over 35.0% in 2021. Live attenuation is the oldest vaccination method used in the veterinary field.
- The recombinant vaccine segment is expected to exhibit lucrative growth over the forecast period. These vaccines help reduce the risk of pathogenicity in animals after vaccination.
Based on the Animal Type Insights, the market is segmented into Livestock, and Companion.
- The livestock segment dominated the market with a revenue share of over 70.0% in 2021. This can be attributed to the factors such as rising livestock population, supportive government initiatives, and the outbreak of diseases among cattle and sheep.
- The companion segment is expected to exhibit the fastest growth rate during the forecast period. Canine distemper virus is carried by house pets as well as ferrets and requires strictly preventive vaccination as no post-infection treatment is available.
Based on the Route of Administration Insights, the market is segmented into Subcutaneous, Intramuscular, and Intranasal.
- The subcutaneous segment dominated the market for animal vaccines with a revenue share of over 40.0% in 2021. In most animals, the subcutaneous injection sites are located behind the shoulder blades and neck.
- The intranasal segment is expected to exhibit the fastest growth rate of 10.0% during the forecast period owing to its increasing popularity. Mostly, intranasal vaccines are limited to a single dose of vaccine.
Based on the Animal Vaccines Regional Insights, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
- North America dominated the market and accounted for a revenue share of over 25.0% in 2021. The region is expected to remain dominant throughout the forecast period.
- In Asia Pacific, the market is expected to register the fastest growth rate during the forecast period. The anticipated rise in the livestock population and government initiatives, especially in developing economies, are some of the prime factors expected to boost the market growth in the region.
Market Share Insights:
- February 2021, Ceva partnered with the French National Research Institute for Agriculture, Food, and Environment (INRAE) for R&D in the prevention of infectious diseases from animal origin and improvement of animal health.
- January 2021, Zoetis launched the Poulvac Procerta HVT-IBD vaccine for the protection of poultry against Infectious Bursal Disease (IBD).
Key Companies Profile:
The market is highly competitive and marked by the presence of various small and large animal vaccine manufacturers. The key parameters affecting competition include rapid adoption of veterinary preventive injections, coupled with government-aided bulk purchase of veterinary vaccines.
Some prominent players in the global animal vaccines market include:
- Merck & Co., Inc.
- Zoetis
- Boehringer Ingelheim International GmbH
- Virbac
- Biogénesis Bagó
- Indian Immunologicals Ltd.
- Elanco
- Ceva
- Phibro Animal Health Corporation
- Neogen Corporation
- Intas Pharmaceuticals Ltd.
- Ourofino Saúde Animal
Order a free sample PDF of the Animal Vaccines Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research is a full-time market research and consulting company registered in San Francisco, California. The company fully offers market reports, both customized and syndicates, based on intense data analysis. It also offers consulting services to business communities and academic institutions and helps them understand the global and business scenario to a significant extent. The company operates across multitude of domains such as Chemicals, Materials, Food and Beverages, Consumer Goods, Healthcare, and Information Technology to offer consulting services.
Web: https://www.grandviewresearch.com
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1888202951
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/veterinary-animal-vaccines-market